The fact that management is putting more skin in the game now counts for a lot. While it does not guarantee that NWBO's problems will be solved, or that the clinical trials will succeed, their action shows that the leaders who invested believe that a good resolution is likely enough to make running the risk worthwhile.
I agree. It seems that NWBO consistently does what it takes to move us forward toward approval. They may not do it the way everyone would perfer or to everyone's desired timing, but it gets done.